贝利木单抗; 贝利尤单抗
Belimumab (Synonyms: LymphoStat B; Anti-TNFSF13B / BAFF / CD257)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Belimumab (Synonyms: LymphoStat B; Anti-TNFSF13B / BAFF / CD257)
CAS356547-88-1
MW144.54 kDa
Security information
Product details

Belimumab (LymphoStat B) is a humanized IgG1λ monoclonal antibody against B-lymphocyte stimulator (BLyS) protein. Belimumab antagonizes BLyS activity in autoimmune diseases and B-lymphocyte malignancies. Belimumab can be used for systemic lupus erythematosus (SLE) research.

Related literature
Related
Sorry, no related items
History
Belimumab (Synonyms: LymphoStat B; Anti-TNFSF13B / BAFF / CD257)
Lampalizumab (Anti-Complement Factor D)
Tarextumab (Anti-NOTCH3)
Efmoroctocog alfa; Efmoroctocog Alfa
Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab; Blincyto; MT103; MEDI-538; MEDI 538; Anti-human CD3 CD19; Human CD3 CD19 bispecific)
Atorolimumab
Donanemab
Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab; JNJ-64407564; JNJ-7564)
(R)-Sulforaphane (Synonyms: L-Sulforaphane; (R)-1-Isothiocyanato-4-(methylsulfinyl)butane; 4-Methylsulfinylbutyl isothiocyanate)
Sevirumab